Erythropoietin and Cardiocirculatory Condition in Aged Patients with Chronic Rena l Failure

2001 
Background/Aim: The clearest benefit of recombinant human erythropoietin (rHuEPO) in end-stage renal disease is a substantial reduction in transfusion dependency and an improved qua
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    7
    References
    12
    Citations
    NaN
    KQI
    []